Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Glycyrrhizin Capsules for localized chronic eczema
ChiCTR-IPR-17011511Phase 4Completed
- Sponsor
- Department of Dermatology, Beijing Friendship Hospital, Capital Medical University
- Start
- Jun 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Compound Glycyrrhizin Capsules group with Placebo capsule group (2 arms). Primary endpoint: EASI score. Started Jun 2015; status: completed.
02
Drugs
glycyrrhizin
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011511.